Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials
Chan XHS. et al, (2024)
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
Faust SN. et al, (2024), The Lancet Child & Adolescent Health
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2023), The Lancet Diabetes & Endocrinology, 11, 905 - 914
Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis
Meskell P. et al, (2023), Cochrane Database of Systematic Reviews, 2023
Raising awareness of antimicrobial resistance: development of an ‘antibiotic footprint calculator’
Prapharsavat R. et al, (2023), Journal of Antimicrobial Chemotherapy, 78, 1317 - 1321
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2023), The Lancet, 401, 1499 - 1507
Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
Imdad A. et al, (2023), Cochrane Database of Systematic Reviews, 2023
Cardiovascular concentration–effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies
Chan XHS. et al, (2023), British Journal of Clinical Pharmacology, 89, 1176 - 1186
Chest radiograph classification and severity of suspected COVID-19 by different radiologist groups and attending clinicians: multi-reader, multi-case study
Nair A. et al, (2022), European Radiology, 33, 2096 - 2104
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Abani O. et al, (2022), The Lancet, 400, 359 - 368
Reducing broad-spectrum antibiotic use in intensive care unit between first and second waves of COVID-19 did not adversely affect mortality.
Chan XHS. et al, (2022), The Journal of hospital infection, 124, 37 - 46
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2022), The Lancet, 399, 665 - 676
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2022), The Lancet, 399, 143 - 151
Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis
Meskell P. et al, (2022), The Cochrane database of systematic reviews, 2022
935. A Hospital Cluster of the Emerging Drug-resistant Yeast Saprochaete clavata
Chan XHS. et al, (2021), Open forum infectious diseases, 8, S560 - S560
Risk factors associated with bloodstream infections among critically ill patients with COVID-19
McMillan T. et al, (2021), Journal of Infection, 83, e1 - e3
The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis
Chan XHS. et al, (2021), PLOS Medicine, 18, e1003766 - e1003766
Performance and impact of disposable and reusable respirators for healthcare workers during pandemic respiratory disease: a rapid evidence review
Burton C. et al, (2021), Occupational and Environmental Medicine, 78, 679 - 690
Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination
Jacob CG. et al, (2021), eLife, 10
Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate
Chaudhry Z. et al, (2021), Journal of Infection, 82, 276 - 316